Hendrick Cancer Center

Abilene, Texas 79601-2316

1 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Chemoradiotherapy-Induced Severe Oral Mucositis, Chronic Lymphocytic Leukemia (CLL), Leukemia, Myeloid, Acute, Lung Cancer, Myelodysplastic Syndromes, Primary Myelofibrosis, Prostatic Neoplasms

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• Connect® Myeloid Disease Registry — Stopped early
• Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer — Completed
• Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. — Stopped early
• informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia — Completed
• An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry) — Completed
• Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer — Stopped early
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed